-- First presentation of preclinical data describing the activity, pharmacokinetics and safety profile of ABI-5366, supporting planned clinical entry in 1H 2024 -- “We are excited to present data for ...

Zika virus (ZIKV) is a mosquito-borne orthoflavivirus that can cause birth defects, including microcephaly, a condition in which head and brain size are significantly reduced at birth. The collective ...

New variants of the SARS-CoV-2 virus most likely will necessitate the development of more vaccine options in the years ahead, and a biomedical scientist at Iowa State University believes the "key" to ...

Researchers have discovered a bacteria-killing virus that may be effective against antibiotic-resistant bacteria. The corresponding study was published in Microbiology. Pseudomonas aeruginosa is a ...

In the movie “Contagion,” a deadly virus created by researchers gets out of the lab and kills millions. Fears of the same thing happening in real life prompted a moratorium on real life tests with the ...

A study published 30 years ago is striking up new conversation about the potential connection between the common cold sore and Alzheimer’s disease. Published in The Lancet in 1997, researchers ...

In early April, Pfizer announced a $525 million acquisition of ReViral’s novel therapy for respiratory syncytial virus (RSV). Since then, RSV therapies have garnered renewed global attention. However, ...

Janssen’s HCV pipeline also includes JNJ-56914845, an investigational NS5A replication complex inhibitor currently in Phase 2 studies, and following the acquisition of Alios BioPharma by Johnson & ...

GSK Plc (NYSE:GSK) shelved on Wednesday its herpes simplex virus (HSV) vaccine development program. The recombinant protein vaccine, dubbed GSK3943104, did not meet the study’s primary efficacy ...